Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 30th, there was short interest totaling 6,992 shares, an increase of 448.0% from the January 15th total of 1,276 shares. Based on an average daily volume of 22,566 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 22,566 shares, the short-interest ratio is presently 0.3 days.
Carl Zeiss Meditec Trading Up 1.0%
Shares of OTCMKTS CZMWY opened at $33.47 on Wednesday. Carl Zeiss Meditec has a 52-week low of $32.02 and a 52-week high of $76.28. The firm’s fifty day moving average is $43.49 and its two-hundred day moving average is $48.60.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on CZMWY shares. The Goldman Sachs Group downgraded shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein lowered Carl Zeiss Meditec to a “market perform” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Carl Zeiss Meditec presently has a consensus rating of “Hold”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
